| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.059 | 0.8 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.012 | 0.9 |